In summary, our pan-cancer analysis of CUL5 initially indicated a significant link – from the perspective of clinical tumor samples – between CUL5 expression and immune cell infiltration, and clinical prognosis or tumor mutational burden, which may improve the understanding of the molecular mechanism of CUL5 during tumorigenesis. The gene discussed is CUL5; the disease is cancer.